NCT04650230

Brief Summary

The purpose of the study was to test the null hypothesis that there is no difference between nasal continuous positive airway pressure / nasal positive pressure ventilation (NCPAP/NPPV) and high flow nasal cannula (HFNC) devices when applied as a first non-invasive respiratory support mode for severe bronchiolitis

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
268

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2013

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

November 25, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 2, 2020

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

3.2 years

First QC Date

November 25, 2020

Last Update Submit

February 23, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of participants with HFNC success

    success was defined by no need of another respiratory support device

    during hospitalization, approximatly 6 days

  • Number of participants with CPAP/NPPV success

    success was defined by no need of another support device

    during hospitalization, approximatly 6 days

Secondary Outcomes (1)

  • rate of intubation

    during hospitalization, approximatly 6 days

Study Arms (2)

high flow nasal cannula (HFNC)

ACTIVE COMPARATOR

Participants in the HFNC group received heated and humidified gas flow with the Fisher \& Paykel Healthcare HFNC system. The flow rate was usually started at the maximum flow rate for the size of cannula and a constant flow temperature of 37 °C.The flow rate will be progressively decreased when inspired fraction of oxygen (FiO2) was inferior to 30 percent (%).

Device: nasal continuous positive airway pressure / nasal positive pressure ventilation (NCPAP/NPPV) and high flow nasal cannula (HFNC) devices

nasal continuous positive airway pressure / nasal positive pressure ventilation (NCPAP/NPPV)

ACTIVE COMPARATOR

Participants in the CPAP/NPPV group received for first CPAP using a neonatal ventilator. The recommended starting pressure for CPAP was +6 centimeter of water (cmH2O). Positive continuous pressure could be increased to a maximum of +8 cmH2O. Optimal positive end expiratory pressure (PEEP) was what could maintain SpO2 at 94 per cent using the lowest fraction of inspired oxygen. PEEP will be decreased progressively of 1cmH2O every 6 hours from the optimal PEEP when FiO2 was inferior to 30% and there is no increase of work of breath.

Device: nasal continuous positive airway pressure / nasal positive pressure ventilation (NCPAP/NPPV) and high flow nasal cannula (HFNC) devices

Interventions

high flow nasal cannula (HFNC)nasal continuous positive airway pressure / nasal positive pressure ventilation (NCPAP/NPPV)

Eligibility Criteria

Age7 Days - 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Clinical diagnosis of bronchiolitis defined as the first viral episode of respiratory distress before 2 years of aging, presenting with rhinitis, tachypnea, cough, wheezing, prolonged expiratory time, crackles and use of accessory muscles, with or without fever, with or without infiltrate on the chest X ray
  • bronchiolitis severity Wang modified score ≥ 10

You may not qualify if:

  • recurrent wheezing
  • heart disease
  • chronic lung disease
  • neuromuscular disease
  • primary diagnosis was not bronchiolitis (pneumonia, pertussis)
  • critically ill infants who had an immediate need of intubation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Bronchiolitis

Interventions

Continuous Positive Airway PressureEquipment and Supplies

Condition Hierarchy (Ancestors)

BronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung Diseases

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 25, 2020

First Posted

December 2, 2020

Study Start

December 1, 2013

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

February 28, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share